Providence Cognitive Assessment Clinic offers clinical and brain imaging assessments of each patient’s cognitive complaints, such as memory loss, concentration problems or changes in problem-solving abilities. Our team includes experts in neurology, neuroimaging, neuropsychology and cognitive rehabilitation. We provide diagnosis and treatment plans for early changes in cognition associated with aging and brain injury.
Providence Cognitive Assessment Clinic is actively engaged in clinical trials to slow patients' memory decline and maintain cognitive health. Treating more than 700 patients a year, Providence Cognitive Assessment Clinic cares for more people with memory disorders than any other health system in Oregon.
Contact us
Providence Cognitive Assessment Clinic
at Providence St. Vincent Medical Center
9427 S.W. Barnes Rd., Suite 595
Portland, OR 97225
503-216-1150 BrainInstitute@Providence.org
Reducing risk and symptoms of Alzheimer's disease Michael Mega, M.D., Ph.D., medical director of Providence Cognitive Assessment Clinic, resently presented research he is conducting to identify what might be the earliest predictors of memory loss. Listen to this KXL interview with Dr. Mega to learn how to recognize the warning signs as well as how treatment can help to reduce the symptoms of Alzheimer’s disease and to improve quality of life. This educational lecture was part of Think * Feel * Function: A learning series about your mind and nervous system, see our events calendar to view upcoming events.
Can coffee prevent memory loss?
Does Alzheimer's disease affect women more than men? Memory expert Michael Mega, M.D., Ph.D., answers these questions and more in a radio interview on KXL. Listen as he discusses new theories and gives tips that can help you recognize early signs of memory-loss conditions.
Alzheimer's disease research study If you have mild to moderate Alzheimer’s disease, you may qualify to take part in a research study that is testing an investigational (not approved by the Food and Drug Administration) drug called bapineuzumab. Bapineuzumab is an antibody against amyloid-β protein, which is thought to cause Alzheimer’s disease. The drug helps remove this protein from the body. Learn more.
2009 Memory Walk Providence is a proud sponsor of the 2009 Alzheimer's Association Memory Walk. Join us at 9 a.m., Sept. 27, at Pioneer Courthouse Square to walk, raise awareness and fund research for Alzheimer's disease. Sign up here.
Television interview explores warning signs of memory loss
Is it dementia or simple forgetfulness? KPTV reporters interviewed Michael Mega, M.D., Ph.D., on the early symptoms of memory loss. Watch the 2008 interview.
Learn about Alzheimer's disease and memory-loss conditions
Our free online medical library offers information you can use on a wide range of topics. Check out these resources on memory-loss conditions:
View images of brain scans showing normal brain tissue compared with tissue affected by Alzheimer’s disease (AD) and frontotemporal dementia.
Are you at risk?
Fill out this “Clinical Dementia Rating (CDR)”. How to use this quiz: If any of the descriptions listed on the CDR quiz seem to fit you, give yourself the number of points assigned to that statement (for example, if you see "CDR 0.5" next to a statement that describes you, give yourself 0.5 points). If your total number of points for the quiz is equal to or greater than 1.5, there is cause for concern. Talk with your doctor about contacting Providence Cognitive Assessment Clinic for an evaluation.
